Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Clindamycin and Salicylic Acid for Acne Vulgaris
NCT00361322Phase 2Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of clindamycin and Salvax in acne vulgaris, sponsored by Hadassah Medical Organization. Primary endpoints: Lesion count at baseline at 0 weeks and Lesion count at the end of study at 8 weeks. Started Apr 2005; status: completed.
02
Drugs
clindamycinSalvax
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00361322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361322.